June 24, 2020
Treatments that block two sugar-transporting proteins could help slow the growth of lung tumours, new research from EPFL suggests.
June 4, 2020
Yale Cancer Center Study Shows Profound Benefit with Targeted Therapy for Patients with Early Stage NSCLC
treatment with the targeted therapy osimertinib following surgery significantly improves disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations
April 2, 2020
Study shows that a simple urine test can reveal the presence of lung cancer in mice.
February 25, 2020
even a tiny amount of a biomarker known as PD-L1 (programmed death-ligand1) can predict a long-term survival benefit from using pembrolizumab (Keytruda).
November 20, 2019
This public-private collaboration enabled researchers identify molecular mechanisms underlying the lack of efficiency of this drug in squamous cell carcinoma
November 6, 2019
MIT cancer biologists have identified a new therapeutic target for small cell lung cancer, an especially aggressive form of lung cancer with limited options for treatment.
October 31, 2019
Researchers have identified a new biomarker that could indicate how likely someone is to respond to treatment for lung cancer
September 10, 2019
Lung cancer can be spotted earlier and diagnosed more precisely with the help of a blood test, a major study carried out in Scotland has found.